Characterization of a serotonin transporter in the parasitic flatworm, Schistosoma mansoni: cloning, expression and functional analysis.

The biogenic amine serotonin (5-hydroxytryptamine: 5HT) is a widely distributed neuroactive substance of vertebrates and invertebrates. Among parasitic flatworms, in particularly the bloodfluke, Schistosoma mansoni, 5HT is an important modulator of neuromuscular function and metabolism. Previous work has shown that schistosomes take up 5HT from host blood via a carrier mediated mechanism. This transport is thought to contribute to the control of schistosome motility in the bloodstream and is essential for survival of the parasite. Here we provide the first molecular evidence for the existence of a 5HT transporter in S. mansoni. A cDNA showing high homology with plasma membrane serotonin transporters (SERT) from other species was cloned and characterized by heterologous expression in cultured HEK293 cells. Functional studies showed that the recombinant schistosome transporter (SmSERT) mediates specific and saturable [(3)H]-5HT transport with a K(t)=1.30+/-0.05 microM. The heterologously expressed protein was inhibited by classic SERT blockers (clomipramine, fluoxetine, citalopram) and the same drugs also inhibited [(3)H]-5HT uptake by intact schistosomula in culture, suggesting that SmSERT may be responsible for this transport. Conventional (end-point) and real-time quantitative RT-PCR analyses determined that SmSERT is expressed both in the free-living stage (cercaria) and parasitic forms of S. mansoni but the expression level is significantly higher in the parasites. These results suggest that SmSERT is upregulated following cercarial transformation, possibly to mediate the recruitment of exogenous 5HT from the host.

[1]  T. Day,et al.  Serotonin and its requirement for maintenance of contractility in muscle fibres isolated from Schistosoma mansoni , 1994, Parasitology.

[2]  R. Blakely,et al.  Cloning, expression, and localization of a chloride-facilitated, cocaine-sensitive serotonin transporter from Drosophila melanogaster. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Mansour,et al.  Serotonin receptors in parasitic worms. , 1984, Advances in parasitology.

[4]  T. Mansour,et al.  Novel serotonin receptors in Fasciola. Characterization by studies on adenylate cyclase activation and [3H]LSD binding. , 1984, Biochemical pharmacology.

[5]  Louis J. DeFelice,et al.  Getting the Message Across: A Recent Transporter Structure Shows the Way , 2006, Neuron.

[6]  R. Podesta,et al.  Schistosoma mansoni: effects of in vitro serotonin (5-HT) on aerobic and anaerobic carbohydrate metabolism. , 1985, Experimental parasitology.

[7]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[8]  R. Blakely,et al.  Cloning and expression of the mouse serotonin transporter. , 1996, Brain research. Molecular brain research.

[9]  D. Williams,et al.  The serotonin transporter: a primary target for antidepressant drugs , 1998, Journal of psychopharmacology.

[10]  M. Gustafsson.  Immunocytochemical demonstration of neuropeptides and serotonin in the nervous system of adult Schistosoma mansoni , 2004, Parasitology Research.

[11]  T. Yoshino,et al.  Pharmacological and autoradiographical characterization of serotonin transporter-like activity in sporocysts of the human blood fluke, Schistosoma mansoni , 2003, Journal of Comparative Physiology.

[12]  H. Horvitz,et al.  Mutations in the Caenorhabditis elegans Serotonin Reuptake Transporter MOD-5 Reveal Serotonin-Dependent and -Independent Activities of Fluoxetine , 2001, The Journal of Neuroscience.

[13]  P. LoVerde,et al.  Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes. , 1997, Experimental parasitology.

[14]  R. A. Webb,et al.  Characterization of a serotonin transporter and an adenylate cyclase-linked serotonin receptor in the cestode Hymenolepis diminuta. , 1987, Life sciences.

[15]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[16]  G. Rudnick,et al.  An extracellular loop region of the serotonin transporter may be involved in the translocation mechanism. , 1997, Biochemistry.

[17]  T. Yoshino,et al.  Schistosoma mansoni: effects of serotonin and serotonin receptor antagonists on motility and length of primary sporocysts in vitro. , 2000, Experimental parasitology.

[18]  J. Padbury,et al.  Placental biogenic amine transporters: cloning and expression. , 1997, Brain research. Molecular brain research.

[19]  T. Mansour,et al.  Schistosoma mansoni: serotonin uptake and its drug inhibition. , 1986, Experimental parasitology.

[20]  D. Mettrick,et al.  Hymenolepis diminuta: uptake of 5-hydroxytryptamine (serotonin), glucose, and changes in worm glycogen levels , 1983 .

[21]  R. A. Webb,et al.  Demonstration of specific high-affinity binding sites for [3H]5-hydroxytryptamine in the cestode Hymenolepis diminuta. , 1986, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology.

[22]  F. Hamdan,et al.  A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamine. , 2002, Molecular and biochemical parasitology.

[23]  Ingebrigt Sylte,et al.  Putative drug binding conformations of monoamine transporters. , 2006, Bioorganic & medicinal chemistry.

[24]  P. Ribeiro,et al.  Classical transmitters and their receptors in flatworms , 2005, Parasitology.

[25]  D. Mettrick,et al.  Circadian variation in the distribution of Hymenolepis diminuta (Cestoda) and 5-hydroxytryptamine levels in the gastro-intestinal tract of the laboratory rat , 1982, Parasitology.

[26]  R. A. Webb,et al.  Localization of a sodium-dependent high-affinity serotonin transporter and recruitment of exogenous serotonin by the cestode Hymenolepis diminuta: an autoradiographic and immunohistochemical study , 1999 .

[27]  M. Sukhdeo,et al.  Hymenolepis diminuta: behavioral effects of 5-hydroxytryptamine, acetylcholine, histamine and somatostatin. , 1984, The Journal of parasitology.

[28]  A. W. Senft,et al.  Schistosome motility measurements: response to drugs. , 1973, The Journal of pharmacology and experimental therapeutics.

[29]  P. Ribeiro,et al.  The 19 S Proteasomal Subunit POH1 Contributes to the Regulation of c-Jun Ubiquitination, Stability, and Subcellular Localization* , 2006, Journal of Biological Chemistry.

[30]  M. Palkovits,et al.  Localization and Dynamic Regulation of Biogenic Amine Transporters in the Mammalian Central Nervous System , 1998, Frontiers in Neuroendocrinology.

[31]  R. Blakely,et al.  Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants* , 2006, Journal of Biological Chemistry.

[32]  T. Day,et al.  Neuromuscular physiology and pharmacology of parasitic flatworms , 1996, Parasitology.

[33]  S. Cook,et al.  Redox Balance Mechanisms in Schistosoma mansoni Rely on Peroxiredoxins and Albumin and Implicate Peroxiredoxins as Novel Drug Targets* , 2006, Journal of Biological Chemistry.

[34]  P. Basch.  Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing. , 1981, The Journal of parasitology.

[35]  F. Hamdan,et al.  Characterization of a Stable Form of Tryptophan Hydroxylase from the Human Parasite Schistosoma mansoni * , 1999, The Journal of Biological Chemistry.